Recent Development Technique in Management of Cancer

Year : 2024 | Volume :13 | Issue : 01 | Page : 25-41
By

    Shruti Morankar

  1. Gangadhar Magar

  1. Student, MET’s Institute of Pharmacy Adgaon, Maharashtra, India
  2. Student, MET’s Institute of Pharmacy Adgaon, Maharashtra, India

Abstract

Cancer develops when a change in one’s genetic makeup leads to the development of tumour cells. These clusters of malignant cells eventually develop into tumours. Tumours can shed cancerous cells, which can then travel through the lymphatic system or the circulatory system to other organs. In the medical field, this occurrence is referred to as metastasis. Cancer cells proliferate even when they have no instructions to do so. Despite the notable advancements in medical technology, such as stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemodynamic therapy, sonodynamic therapy, and ferroptosis-based therapy, traditional treatment methods such as surgery, chemotherapy, and radiation remain prevalent. These traditional procedures continue to be utilised due to their established efficacy, widespread availability, and proven track record in treating various medical conditions across diverse patient populations. Today, oncology practices are centered on developing safe and efficient nanomedicines for the treatment of cancer. Nanoparticles have provided new diagnostic and therapeutic options, and stem cell treatment has shown extraordinary efficacy in regenerating and repairing sick or damaged tissues, including those at the main and metastatic cancer foci.

Keywords: malignancy, ablation therapy, ferroptosis-based therapy, radionics, apoptosis, sonodynamic-based therapy

[This article belongs to Research & Reviews: Journal of Oncology and Hematology(rrjooh)]

How to cite this article: Shruti Morankar, Gangadhar Magar.Recent Development Technique in Management of Cancer.Research & Reviews: Journal of Oncology and Hematology.2024; 13(01):25-41.
How to cite this URL: Shruti Morankar, Gangadhar Magar , Recent Development Technique in Management of Cancer rrjooh 2024 {cited 2024 Apr 20};13:25-41. Available from: https://journals.stmjournals.com/rrjooh/article=2024/view=143816


References

  1. Olsson M, Zhivotovsky B. Caspases and cancer. Cell Death & Differentiation. 2011; 18(9): 1441–1449p.
  2. Weinberg R How cancer arises. Scientific American. 1996;275(3): 62–70p.
  3. Mantyh PW. Cancer pain: causes, consequences and therapeutic opportunities. In: Wall and Melzack’s Textbook of P USA: Saunders; 2006.1087–1097p.
  4. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute. 1981; 66(6): 1192–1308p.
  5. Clapp RW, Jacobs MM, Loechler EL. Environmental and occupational causes of cancer: new evidence 2005–2007. Reviews on Environmental H 2008; 23(1): 1–38p.
  6. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature m 2004; 10(8): 789–799p.
  7. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012; 486(7403): 400–404p.
  8. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484): 495–501p.
  9. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484): 495–501p.
  10. Wodarz A, Näthke I. Cell polarity in development and cancer. Nature Cell Biology. 2007; 9(9): 1016–1024p.
  11. Frederic EM, Lathrop TG. Modes of spread of cancer of skin. AMA Archives of Dermatology and Syphilology. 1952; 66(4): 427–439p.
  12. Kirchner JA, Carter D. Intralaryngeal barriers to the spread of cancer. Acta Oto-Laryngologica. 1987; 103(5–6): 503–513p.
  13. Brossart The Role of Antigen Spreading in the Efficacy of Immunotherapies Epitope Spreading in Cancer Immunotherapy. Clinical Cancer Research. 2020;26(17): 4442–4447p.
  14. Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, et al. 2D and 3D cell cultures–a comparison of different types of cancer cell cultures. Archives of Medical Science. 2018;14(4): 910–919p.
  15. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. The Journal of Clinical I 2005; 115(6): 1503–1521p.
  16. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, et al; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Annals of Internal M 2008; 148(10): 728–736p.
  17. Saunders C The care of the terminal stages of cancer. Annals of the Royal College of Surgeons of England. 1967;41(Suppl): 162p.
  18. Qi F, Zhao L, Zhou A, Zhang B, Li A, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Bioscience Trends. 2015;9(1): 16–34p.
  19. McMahon KW, Karunasena E, Ahuja The roles of DNA methylation in the stages of cancer. Cancer Journal. 2017;23(5): 257p.
  20. Rami-Porta R, Crowley JJ, Goldstraw Review the revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15(1): 5p.
  21. Puppa G, Sonzogni A, Colombari R, Pelosi TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Archives of Pathology & Laboratory Medicine. 2010;134(6): 837–852p.
  22. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA: A Cancer Journal for C 2005; 55(4): 242–258p.
  23. Lababede O, Meziane M, Rice Seventh edition of the cancer staging manual and stage grouping of lung cancer: Quick reference chart and diagrams. Chest. 2011;139(1): 183–189p.
  24. Detterbeck FC, Boffa DJ, Tanoue L The new lung cancer staging system. Chest. 2009;136(1): 260–271p.
  25. Hajj C, Goodman K Role of radiotherapy and newer techniques in the treatment of GI cancers. Journal of Clinical Oncology. 2015;33(16): 1737–1744p.
  26. Lipsett M Newer techniques and some problems in cooperative group studies. In:Conference on Experimental Clinical Cancer Chemotherapy; USA: National Cancer Institute; 1960.18: 277p.
  27. Schnitt S Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Modern Pathology, 2010; 23: S60–S64.
  28. Herberts CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J Transl Medicine. 2011;9(1): 1–14p.
  29. Biehl JK, Russell Introduction to stem cell therapy. The Journal of Cardiovascular Nursing. 2009;24(2): 98p.
  30. Sagar J, Chaib B, Sales K, Winslet M, Seifalian Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell International. 2017;7(1): 1–11p.
  31. Jenq RR, Van den Brink M Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nature Reviews Cancer. 2010;10(3): 213–221p.
  32. Vasir JK, Labhasetwar Targeted drug delivery in cancer therapy. Technology in Cancer Research & Treatment. 2005;4(4): 363–374p.
  33. Pérez-Herrero E, Fernández-Medarde Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 93: 52–79p.
  34. Jain K Targeted drug delivery for cancer. Technology in Cancer Research & Treatment. 2005; 4(4): 311–313p.
  35. Roth JA, Cristiano RJ. Gene therapy for cancer: what have we done and where are we going?. Journal of the National Cancer Institute. 1997; 89(1): 21–39p.
  36. Schmitt TM, Gunnar BR, Greenberg PD. T cell receptor gene therapy for cancer. Human Gene Therapy. 2009; 20(11): 1240–1248p.
  37. Rosenberg S Gene therapy for cancer. JAMA. 1992; 268(17): 2416–2419p.
  38. Mauri G, Nicosia L, Xu Z, Di Pietro S, Monfardini L, et al. Focused ultrasound: Tumour ablation and its potential to enhance immunological therapy to cancer. The British Journal of Radiology. 2018;91(xxxx):
  39. Friedman M, Mikityansky I, Kam A, Libutti SK, Walther MM, et al. Radiofrequency ablation of cancer. Cardiovascular and Interventional Radiology. 2004;27(5): 427–434p.
  40. Ashikbayeva Z, Tosi D, Balmassov D, Schena E, Saccomandi P, et al. Application of nanoparticles and nanomaterials in thermal ablation therapy of cancer. Nanomaterials. 2019;9(9):
  41. Block K Antioxidants and cancer therapy: Furthering the debate. Integrative Cancer Therapies. 2004;3(4): 342–348p.
  42. Valadez-Vega C, Delgado-Olivares L, Gonzalez JAM, Garcia EA, Ibarra JRV, et al. The role of natural antioxidants in cancer disease. In: Oxidative stress and chronic degenerative diseases-A role for antioxidants. IntechOpen;
  43. Brigger I, Dubernet C, Couvreur Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews. 2012;64: 24–36p.
  44. Aghebati‐Maleki A, Dolati S, Ahmadi M, Baghbanzhadeh A, Asadi M, et al. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Journal of Cellular Physiology. 2020;235(3): 1962–1972p.
  45. Tansley D Radionics & the subtle anatomy of man. USA: Random House; 2011.
  46. Andreadis E, Saliangas K, Economou A, Nikoloudis N, Manna I, et al. Application of radionics on primary and metastatic tumours of the liver. Techniques in Coloproctology. 2004;8(1): 184–186p.
  47. Wang X, Zhong X, Liu Z, Cheng Recent progress of chemodynamic therapy-induced combination cancer therapy. Nano Today. 2020;35: 100946.
  48. Li SL, Jiang P, Jiang FL, Liu Recent advances in nanomaterial‐based nanoplatforms for chemodynamic cancer therapy. Advanced Functional Materials. 2021;31(22): 2100243.
  49. Chen H, Zhou X, Gao Y, Zheng B, Tang F, et al. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug Discovery Today. 2014;19(4): 502–509p.
  50. Xu M, Zhou L, Zheng L, Zhou Q, Liu K, et al. Sonodynamic therapy-derived multimodal synergistic cancer therapy. Cancer Letters. 2021;497: 229–242p.
  51. Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, et al. Recent advances in sonodynamic approach to cancer therapy. Ultrasonics Sonochemistry. 1996;3(3): S187–S191.
  52. Shen Z, Song J, Yung BC, Zhou Z, Wu A, et al. Emerging strategies of cancer therapy based on ferroptosis. Advanced Materials. 2018;30(12):
  53. Michael M, Tannock I Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ. 1998;158(13): 1727–1734p.
  54. Coffey JC, Wang JH, Smith MJF, Bouchier-Hayes D, Cotter TG, et al. Excisional surgery for cancer cure: Therapy at a cost. The Lancet Oncology. 2003;4(12): 760–768p.
  55. Hayes D Biomarker validation and testing. Molecular Oncology. 2015;9(5): 960–966p.
  56. Lim C, Tsao MS, Le LW, Shepherd FA, Feld R, et al. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer. Annals of Oncology. 2015;26(7): 1415–1421p
  57. Kuhle CL, Kapoor E, Sood R, Thielen JM, Jatoi A, et al. Menopausal hormone therapy in cancer survivors: a narrative review of the literature. Maturitas. 2016; 92: 86–96p.
  58.  Abraham J, Ocen J, Staffurth J. Hormonal therapy for cancer. Medicine. 2022; 44(1): 30–33p.
  59.  Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, et al. Immunotherapy of cancer in 2012. CA: A Cancer Journal for Clinicians. 2012; 62(5): 309–335p.
  60.  Melief CJ, Toes RE, Medema JP, Burg SHV, Cornelis JM, et al. Strategies for immunotherapy of cancer. Adv Immunol. 2000; 75: 235–282p.
  61. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, et al. Photodynamic therapy. JNCI: Journal of the National Cancer Institute. 1998; 90(12): 889–905p.
  62.  Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, et al. Photodynamic therapy of cancer: an update. CA: A Cancer Journal for Clinicians, 2011; 61(4): 250–281p.
  63.  Hahn GM. Hyperthermia and cancer. Germany: Springer Science & Business Media; 2012.
  64.  Baronzio GF, Hager ED, eds. Hyperthermia in cancer treatment: A primer. Germany: Springer Science & Business Media; 2008.
  65. Wan GY, Liu Y, Chen BW, Liu YY, Wang YS, et al. Recent advances of sonodynamic therapy in cancer treatment. Cancer Biology & Medicine. 2016; 13(3): 325p.
  66. Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. Journal of Hematology & Oncology. 2019; 12(1): 1–13p.
Regular Issue Subscription Review Article
Volume 13
Issue 01
Received March 3, 2024
Accepted March 7, 2024
Published April 20, 2024
Views: 21